Early diagnosis and management are crucial in spondyloarthritis

Joint Bone Spine

Volumn 80, Issue 6, 2013, Pages 582-585

  Wendling, Daniel ^a   Claudepierre, Pascal ^b   Prati, Clément ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Diagnostic delay; Spondyloarthritis; Treatment

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENTEEISM; DISEASE DURATION; DISEASE SEVERITY; EARLY DIAGNOSIS; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; INCOME; MEDICAL LEAVE; PATIENT CARE; PATIENT CODING; QUALITY OF LIFE; RADIODIAGNOSIS; SHORT SURVEY; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; THERAPY DELAY; WORK CAPACITY; COST OF ILLNESS; DELAYED DIAGNOSIS; HUMAN;

COST OF ILLNESS; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; HUMANS; SPONDYLARTHRITIS;

EID: 84888435440     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.03.003     Document Type: Short Survey

References (31)

1. Dougados M., Baeten D. Spondyloarthritis. Lancet 2011, 377:2127-2137.
2. Poddubnyy D., Rudwaleit M. Early spondyloarthritis. Rheum Dis Clin N Am 2012, 38:387-403.
3. Saraux A., Guillemin F., Guggenbuhl P., et al. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005, 64:1431-1435.
4. Boonen A., van der Linden S. The burden of ankylosing spondylitis. J Rheumatol 2006, 33:4-11.
5. Feldtkeller E., Khan M.A., van der Heijde D., et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003, 23:61-66.
6. Oniankitan O., Ranaivo N., Carton L., et al. Poorly and well controlled spondyloarthropathies: a comparison of 2 groups of patients. J Rheumatol 2005, 32:77-79.
7. Montacer Kchir M., Mehdi Ghannouchi M., Hamdi W., et al. Impact of the ankylosing spondylitis on the professional activity. Joint Bone Spine 2009, 76:378-382.
8. Boonen A. A review of work-participation, cost of illness and cost-effectiveness studies in ankylosing spondylitis. Nat Clin Pract Rheumatol 2006, 2:546-553.
9. Boonen A., Severens J.L. Ankylosing spondylitis: what is the cost to society, and can it be reduced?. Best Pract Res Clin Rheumatol 2002, 16:691-705.
10. Strömbeck B., Englund M., Bremander A., et al. Cost of illness from the public payers' perspective in patients with ankylosing spondylitis in rheumatological care. J Rheumatol 2010, 37:2348-2355.
11. Boonen A., van der Heijde D., Landewé R., et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002, 61:429-437.
12. Boonen A., Chorus A., Miedema H., et al. Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 2001, 60:1033-1039.
13. Boonen A., Brinkhuizen T., Landewé R., et al. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010, 69:1123-1128.
14. Ibn Yacoub Y., Amine B., Laatiris A., et al. Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis. Rheumatol Int 2012, 32:357-360.
15. Aggarwal R., Malaviya A.N. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes. An Indian perspective. Clin Rheumatol 2009, 28:327-331.
16. Salvadorini G., Bandinelli F., Delle Sedie A., et al. Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. Clin Exp Rheumatol 2012, 30:561-565.
17. Guillemin F., Briançon S., Pourel J., et al. Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 1990, 33:1001-1006.
18. Mathieu S., Gossec L., Dougados M., et al. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011, 63:557-563.
19. Prati C., Claudepierre P., Pham T., et al. Mortality in spondylarthritis. Joint Bone Spine 2011, 78:466-470.
20. Bakland G., Gran T., Nossent J.C. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011, 70:1921-1925.
21. Stone M., Warren R.W., Bruckel J., et al. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 2005, 53:445-451.
22. Wendling D., Claudepierre P. Ossification in axial spondyloarthritis. Joint Bone Spine 2013, 10.1016/j.jbspin.2013.02.004.
23. Braun J., van den Berg R., Baraliakos X., et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011, 70:896-904.
24. Wendling D., Prati C., Claudepierre P., et al. Non-radiographic spondyloarthritis: a theoretical concept or a real entity?. Joint Bone Spine 2012, 79:531-533.
25. van der Heijde D., Sieper J., Maksymowych W.P., et al. 2010 update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 2011, 70:905-908.
26. Pham T., Fautrel B., Dernis E., et al. Recommendations of the French Society for Rheumatology regarding TNF-alpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 2007, 74:638-646.
27. Rudwaleit M., Sieper J. Referral strategies for early diagnosis of axial spondyloarthritis. Nat Rev Rheumatol 2012, 8:262-268.
28. Kemta Lekpa F., Lenczner G., Farrenq V., et al. Comment intégrer l'imagerie moderne dans le diagnostic précoce et le suivi de la spondylarthrite ankylosante?. J Radiol 2010, 91:162-172. [In French].
29. Dougados M., d'Agostino M.A., Benessiano J., et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011, 78:598-603.
30. Claudepierre P., Wendling D., Breban M., et al. Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: what's in a name?. Joint Bone Spine 2012, 79:534-535.
31. Malaviya A.P., Ostor A.J. Early diagnosis crucial in ankylosing spondylitis. Practitioner 2011, 255:21-24.